Log in

ResultsNDTV Profit

Natco Pharma shares rally 9% despite weak Q2 results

Negative-67Company event

GreyOak summary

Natco Pharma shares surged 8.64% to Rs 882.45 despite reporting a 60.8% YoY drop in net profit to Rs 203 crore in Q2FY27. Revenue fell 29% to Rs 967 crore, and EBITDA margins compressed by 1,580 bps to 26.7%.

What it affects

Source

Read the original at NDTV Profit

More Natco Pharma news

All Natco Pharma news →